H
ippocrates (460 to 370 BC) first described the colorless vessels that are now recognized as comprising the lymphatic vasculature; however, few studies focused on these specialized vessels in the ensuing 2,000-year period (1) . Historically, the reason why this research has evolved so slowly is due to the technical difficulty in visualizing the colorless lymphatic vasculature. In the early 20th century, Florence Sabin injected ink into pig embryos and discovered that lymphatic vessels originated from out-sprouting of existing veins during development (2) . Not until the end of the 20th century, when the lymphatic vasculature could be specifically visualized through the discovery of key genes that faithfully marked lymphatic endothelial cells, was it possible to truly observe and appreciate lymphatic anatomy (3) (4) (5) . For this reason, the very presence of lymphatic vessels in some anatomic locations is still being described. For instance, in the central nervous system, lymphatic vessels in the meningeal membranes around the brain have only recently been discovered, where they function to facilitate immune cell and cerebral interstitial fluid drainage from the brain (6) (7) (8) (9) . In the eye, a specialized structure referred to as Schlemm's canal bears features of lymphatic vessels and regulates intraocular pressure (7, 9, 10) . Novel functions of the lymphatic vasculature have also recently emerged, including a key role in preparing the developing lung for inflation at birth to avoid respiratory neonatal failure (11) . Progress has also been made in defining a role for lymphatic vessels in transporting cholesterol from the artery wall to reduce risk of atherosclerosis. We have recently reviewed this subject, but we will not discuss it here (12) .
Progress in lymphatic vessel research has also emerged in the heart. This review focuses on the current understanding of cardiac lymphatic biology. First, we describe the origin of the cardiac lymphatic vasculature during development and then review overall cardiac lymphatic anatomy and function.
Finally, we discuss the potential of therapeutic strategies to target cardiac lymphatic vasculature.
ORIGIN OF THE SYSTEMIC LYMPHATIC VASCULATURE
The lymphatic system includes lymphatic vessels, lymph nodes, and lymphoid organs (13) . Different from the circulatory blood vessels, lymphatic vessels are structurally blind-ended at their distal segments.
These blind ends form vessels that are designed to absorb interstitial fluid and immune cells and are called lymphatic capillaries. These vessels converge onto deeper lymphatic structures called collecting vessels that are equipped with valves and a muscular wall that promotes transport rather than absorption.
Flow in the lymphatic vasculature as a whole is unidirectional and is designed to drain extravascular fluid, macromolecules, and immune cells back into the venous system to maintain interstitial fluid balance. The cells also transport absorbed lipids such as chylomicron particles from the gut, and throughout the body they function as a key structure in immune surveillance (12, 14) . Despite much progress in all aspects of lymphatic vessel research, the organs from which the lymphatic vascular system originate is still under debate. As mentioned above, more than 100 years ago, lymphatic vessels were suggested to originate from lymph sacs by Florence Sabin (2). Sabin's early work was found consistent with results shown later in mouse (15) and zebrafish (16) .
An alternative proposed by Huntington and
McClure (17) hypothesized that peripheral lymphatics arose from a nonvenous source through lymphangioblasts that gave rise to lymph sacs, suggesting that the origin of lymphatic vasculature is mixed. In 
FLOW PATTERNS OF CARDIAC LYMPH
The cardiac lymphatic vasculature was first described Huang et al.
Heart Lymphatics Impact Myocardial Infarction the other vessel (right) runs along the left cardiac vein and passes the coronary sinus and left atrium upward to the mediastinum.
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Heart Lymphatics Impact Myocardial Infarction Many concepts, including flow and lymphangiogenic response to inflammation, are borrowed from the lesson learned from the skin. Although those concepts may apply to the heart as well, they are also likely to be organ-specific mechanisms. Clearly, there will be many new connections to be discovered as we explore the lymphatic field in full.
LYMPHANGIOGENESIS AS A TARGET TO PROMOTE HEART FUNCTION AFTER INJURY
After myocardial infarction, when much tissue is destroyed, the restoration of even the basal density of lymphatic vessels is needed to restore interstitial flow. The basal lymphangiogenic response is quite robust in humans (66, 67) and also in animals (23, 68) .
The increases in lymphatic density are sustained during the healing phase, longer than that of blood vessels (66) . Perhaps there is a prolonged need for Increased lymphangiogenesis of lymphatic capillaries and pre-collecting and collecting vessels remodeling after treating the infarct heart with VEGF-C improves cardiac functions in the infarcted heart. VEGF ¼ vascular endothelial growth factor.
that negatively impacted fluid transport from infarcted and adjacent uninfarcted areas (68). Thus, it is possible that, although lymphangiogenesis of the small, blind-ended lymphatic capillaries garners attention most readily because this change is most obvious (23), the most relevant therapeutic target may be sustaining function of the deeper collecting lymphatic vessels (68) . Collectively, these 2 studies raise a promising new approach to restoring the heart after myocardial infarction and highlight the potential that additional work on the lymphatic vasculature in the cardiac system may yield in treating dysfunction of the heart (Central Illustration).
CONCLUSIONS
Although the lymphatic vasculature in the heart has been studied for some time, recent studies in the field have introduced for the first time the possibility that heart conditions such as ischemia and infarction may be treated by direct targeting of the lymphatic vasculature. In particular, the therapeutic administration of VEGF-C in 2 different studies improved the rate and quality of cardiac healing in experimental myocardial infarction in mice and rats.
The positive outcome may be attributed to increased lymphangiogenesis of lymphatic capillaries in the heart but may otherwise also relate to sustained functionality of the deeper lymphatic collecting vessels. There is much work to be done in considering lymphatic transport as a means to combat adverse events in the heart. The lymphatic vessels of the heart deserve increased attention.
